Non-invasive in vivo determination of viable islet graft volume by 111 In-exendin-3.

MLA

Eter, Wael A., et al. “Non-Invasive in Vivo Determination of Viable Islet Graft Volume by 111 In-Exendin-3.” Scientific Reports, vol. 7, no. 1, Aug. 2017, p. 7232. EBSCOhost, https://doi.org/10.1038/s41598-017-07815-3.

APA

Eter, W. A., Van der Kroon, I., Andralojc, K., Buitinga, M., Willekens, S. M. A., Frielink, C., Bos, D., Joosten, L., Boerman, O. C., Brom, M., & Gotthardt, M. (2017). Non-invasive in vivo determination of viable islet graft volume by 111 In-exendin-3. Scientific Reports, 7(1), 7232. https://doi.org/10.1038/s41598-017-07815-3

Chicago

Eter, Wael A, Inge Van der Kroon, Karolina Andralojc, Mijke Buitinga, Stefanie M A Willekens, Cathelijne Frielink, Desiree Bos, et al. 2017. “Non-Invasive in Vivo Determination of Viable Islet Graft Volume by 111 In-Exendin-3.” Scientific Reports 7 (1): 7232. doi:10.1038/s41598-017-07815-3.